Literature DB >> 16873055

CK2 and PML: regulating the regulator.

Valérie Lallemand-Breitenbach1, Hugues de Thé.   

Abstract

The PML protein induces senescence, and, upon oncogenic stress, its absence promotes cellular transformation. In this issue of Cell, Scaglioni et al. (2006) show that phosphorylation of PML by CK2, a kinase frequently activated in human cancers, promotes PML degradation. Therefore, pharmacological inhibition of CK2-induced PML loss could be used to offset tumor establishment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873055     DOI: 10.1016/j.cell.2006.07.004

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  5 in total

Review 1.  Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity.

Authors:  Odile Filhol; Sofia Giacosa; Yann Wallez; Claude Cochet
Journal:  Cell Mol Life Sci       Date:  2015-05-20       Impact factor: 9.261

Review 2.  CK2 and the Hallmarks of Cancer.

Authors:  May-Britt Firnau; Angela Brieger
Journal:  Biomedicines       Date:  2022-08-16

Review 3.  Nuclear microenvironment in cancer diagnosis and treatment.

Authors:  Rossanna C Pezo; Robert H Singer
Journal:  J Cell Biochem       Date:  2008-08-15       Impact factor: 4.429

4.  The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies.

Authors:  Feroz Sarkari; Xueqi Wang; Tin Nguyen; Lori Frappier
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

5.  PML(NLS(-)) inhibits cell apoptosis and promotes proliferation in HL-60 cells.

Authors:  Yuan-Mei Gao; Liang Zhong; Xi Zhang; Xiu-Xiu Hu; Bei-Zhong Liu
Journal:  Int J Med Sci       Date:  2013-03-05       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.